HIV/AIDS Information Center Archive
The two most prevalent HIV symptoms, fatigue and muscle aches, are more common in women than men and can worsen with menopause.
A new antiretroviral HIV treatment, Trogarzo (ibalizumab-uiyk), has been approved by the FDA for patients with HIV who have not have success with past HIV medications.
Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.
Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.
Excessive alcohol consumption does not impact the decline of CD4 cell count in patients with HIV who have not undergone antiretroviral treatments.
Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.
For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective.
Post-seroconversion brain morphology can occur in HIV patients, but aviremia maintenance via cART can slow of prevent brain injuries.
A new report from the CDC finds that HIV is being diagnosed sooner after initial infection than in previous years.
Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.
The decrease in HIV incidence in Uganda was facilitated by antiretroviral therapy, male circumcision, and adolescent abstinence.
More tests might be administered to transgender individuals who are female, black, or sex workers.
The dual combination of dolutegravir plus darunavir/ritonavir provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.
Hepatitis B and hepatitis C may increase mortality risks in HIV patients.
The Ohio Supreme Court has unanimously upheld the constitutionality of a law requiring HIV-infected individuals to tell their sexual partners of their illness.
The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.
Resistance to ART is threatening the recent gains of treatment in the rate of new HIV infections.
More than half of women receiving a new HIV diagnosis have already received this diagnosis in the past but are not undergoing HIV medical care.
Infection was diagnosed at an early stage for fewer males with infection attributed to heterosexual contact vs male-to-male sexual contact.
The HIV Medicine Association of the Infectious Disease Society of America recommends that people living with HIV be screened for pain and offered both nonpharmacologic and pharmacologic treatment options.
Virological response, efficacy, noninferiority, and tolerability were tested for bictegravir, emtricitabine, and tenofovir alafenamide in patients with HIV.
In 16 countries, notification rates for new HIV diagnoses in older adults increased significantly, clustering in central and eastern European countries.
Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide was well tolerated in children and maintained high virological suppression.
High-dose vitamin D supplements improve bone mineral density in youth with HIV.
Alternative treatments should be offered to pregnant women with HIV instead of tenofovir or emtricitabine.
Smartphone-based electronic reader reliable for point-of-care tests in HIV and T pallidum infections
The findings shed new light on the applicability of smartphone-based electronic readers in point-of-care testing.
Adherence decreased over time in adolescent MSM who participated in a 48-week HIV PrEP intervention.
Women with mental illness engage in significantly more sexually risky behaviors than men, and personality risk scores are a significant predictor of total sex acts for women but not men.
Rapid HIV testing offered in parallel to patient-clinician consultations increases the testing rate in the emergency department.
The new guidelines address the issue of how to manage pretreatment HIV drug resistance in countries where the prevalence of is 10% or higher.
A child who was diagnosed with HIV at 1 month and received early treatment has suppressed the virus without anti-HIV therapy for 8.5 years.
The investigators found that after 32 weeks, HIV remained suppressed in 91% percent of those taking the drugs orally, 94% of those receiving monthly injections, and 95% of patients receiving injections every two months.
HIV, hepatitis B, and hepatitis C infections are more common among individuals with severe mental illness.
The update includes 30 new medicines for adults and 25 for children and groups antibiotics into 3 distinct categories.
Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.
Providers in 17 new Walgreens locations will be able to prescribe PrEP for HIV prevention.
The drug is indicated for use in combination with other antiretroviral agents for the treatment of pediatric and adult patients with HIV-1.
The CDC found that 28% of young men who have sex with men have undergone HIV testing, though they account for 83% of new diagnoses.
Hepatitis C treatment in HIV coinfection cases is effective with standardized nurse and pharmacist support for patients in an urban clinic.
Treatment with amphotericin B was superior to itraconazole as an induction therapy for HIV-associated talaromycosis.
Continued antiretroviral therapy was found to be safe and beneficial in HIV-positive postpartum women with high CD4+ T cell counts.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Factors linked to health-related quality of life in military HIV patients include advanced HIV disease and mental or medical comorbidity.
Strategies are available to reduce the risk of HIV transmission using sperm from HIV-infected male.
Researchers predict that the infection rate could be as low as 12,000 people a year by 2025.
Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSM
Among HIV-uninfected men aged 50 to 70, heavy popper use was associated with an increased risk of virus-associated cancer with causes linked to HPV, HHV-8, and Epstein-Barr virus.
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
The FDA Drug Interactions section has been updated to include revised information on concomitant use of corticosteroids with these drugs.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
A World Health Organization expert panel recommended lay health care workers be allowed to conduct HIV testing services using rapid diagnostic tests.
However, missed opportunities for prevention were common among infected infants and their mothers in recent years.
The HIV-positive population of the United Kingdom has a higher risk of death than the general population, despite availability of free treatment and care.
A VA center in Wisconsin is advising veterans to be screened for hepatitis and HIV after receiving care from a dentist who did not follow VA procedures.
The study will be the largest HIV vaccine clinical trial to take place in South Africa.
The number of patients dying from infections has remained stable, but some disease threats have changed.
Antenatal ART reduces rates of early HIV transmission but may increase risk of adverse maternal and neonatal outcomes.
Men and women who quit smoking after entering HIV care at age 40 years gained 5.7 years and 4.6 years of life expectancy, respectively, compared with those who continued to smoke.
HIV-infected individuals should receive the meningococcal conjugate vaccine (serogroups A, C, W, and Y).
The study debunks the theory that Patient Zero was responsible for the AIDS epidemic in North America.
Speakers at IDWeek 2016 addressed the demand for additional HIV care providers.
Recent data suggest that use of depot medroxyprogesterone acetate may increase women's HIV acquisition risk.
Patients with HIV receiving antiretroviral treatment have a higher risk of non-Hodgkin's lymphoma with HBV and HCV coinfection.
Treatment with 3 medications compared with 4 or more correlated with immune success at the end of follow-up.
The results of a multicenter, cross-sectional study showed that 37% of patients could have been diagnosed with HIV at an earlier stage.
The efficacy and safety of ART have greatly improved with the newer drug classes of antiretrovirals.
Researchers analyzed data from 21 jurisdictions conducting HIV incidence surveillance from 2007 to 2013.
Patients with HIV infection with immediate access to antiretroviral therapy may have a reduced risk of infection-related cancer.
Free self-test kits were advertised among a population of high-risk MSM.
Researchers observed 78 HIV-1 among partners, with an annual incidence of 0.9%.
The use of injectable, extended-release oxymorphone and syringe sharing was linked to an outbreak of HIV infections in Indiana.
Patients with HIV infection and elevated viral load are likely to progress to advanced hepatic fibrosis.
Children who were perinatally exposed to HIV are more likely to struggle with psychosocial adjustment during childhood and adolescence.
Many women were found to have poor postpartum virologic control.
More than 30% of women with HIV and no prehysterectomy had abnormal Pap test results.
The relationship between HIV and STI rates and race/ethnicity and partner characteristics should be considered in future HIV intervention.
Antiretroviral therapy in HIV-positive patients did not decrease the progression of arterial inflammation.
Many HIV-positive patients who meet the criteria for COPD are not receiving proper treatment.
Signs and symptoms are not typically observed during acute HIV-1 infection.
Researchers found that shared decision making is effective when managing medication therapy in patients.
A study has found no evidence that programs promoting abstinence can reduce risky sexual behaviors that can increase the risk of HIV.
Instances of new HIV infections decreased by 11%.
The rates of many cancers increase in in HIV positive individuals.
A renal transplant recipient experienced drug interaction-induced calcineurin inhibitor nephrotoxicity after starting a cobicistat-containing combination treatment for HIV.
Patients with HIV have an increased risk of clinical nonadherence, which can be improved with text message alerts.
Pregnant women with HIV who undergo antiretroviral therapy may have an increased risk of preterm birth, low birth weight, and small-for-gestational age infants.
Treatment guidelines must expand to focus on patients co-infected with both HCV and HIV.
Patients with HCV/HIV coinfections had a much higher risk of HCV recurrence.
Overall quality of the studies reviewed was poor, leaving gaps in the development treatment recommendations for MC.
HIV-infected male adolescents present with elevated rates of bone loss due to immune dysregulation, chronic inflammation, and antiretroviral therapy.
Gilead Sciences has received approval to indicate Truvada for pediatric patients with HIV-1.
Men who have sex with men who disclosed their sexual identity to their providers were more likely to receive appropriate health services, including routine HIV testing and hepatitis vaccinations.
Odefsey combines emtricitabine and tenofovir alafenamide with rilpivirine to treat HIV-1.
Rapid initiation of antiretroviral therapy will likely reduce the number of HIV-related deaths.
HIV-1 incidence was reduced by 27% among all study participants.
More than 65% of patients in the "opt-out" group accepted the HIV test, according to researchers.
High school aged males were less likely to have been tested than females.
Men who have sex with men can reduce their risk of contracting HIV by taking PrEP before and after sex instead of every day.
Breastfeeding mothers who are HIV-positive can prevent transmission to their infants through a lopinavir-ritonavir or lamivudine regimen.
To combat the stigma associated with selective screening, the American Academy of Pediatrics has called for all children to be screened for high cholesterol, depression, and HIV.
The CDC said that too few Americans who have an increased risk for HIV are taking the PrEP pill to help protect them against HIV.